MDC Pharmaceuticals
Ticker > Company >

MDC Pharmaceuticals share price

MDC Pharmaceuticals Ltd.

SECTOR: Pharmaceuticals & Drugs  1860   0   0

The company is currently not listed and is under IPO, so all the data might not be available.
*It is just an analytical rating of the company and not an investment advice.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year0.06%
3 Year9.82%
5 YearNA

Profit Growth

1 Year128.25%
3 Year19.8%
5 YearNA

ROE%

1 Year16.91%
3 Year9.72%
5 Year9.93%

ROCE %

1 Year24.08%
3 Year15.45%
5 Year14.85%

Debt/Equity

0.156700866089274

Price to Cash Flow

0

Interest Cover Ratio

5.53909173662385

CFO/PAT (5 Yr. Avg.)

0

 Strengths

  • The company has significantly decreased its debt by 5.0103 Cr.
  • The company has an efficient Cash Conversion Cycle of 61.3728933527138 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 405.179469764679.

 Limitations

  • The company has shown a poor revenue growth of 9.81854802344337% for the Past 3 years.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017
Net Sales 34.48 35.94 40.99 47.57 47.6
Total Expenditure 30.87 31.26 38 43.58 41.04
Operating Profit 3.62 4.68 2.99 4 6.56
Other Income 0.17 0.02 0.29 0.29 0.05
Interest 1.81 1.63 1.28 1.16 0.99
Depreciation 0.86 0.95 1.42 1.02 1.14
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.12 2.12 0.58 2.1 4.49
Tax 0.2 0.42 0.04 0.82 1.56
Net Profit 0.93 1.7 0.55 1.28 2.93
Adjusted EPS (Rs.) 0.77 1.42 0.46 1.07 2.44

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2014 Mar 2015 Mar 2016 Mar 2017
Equity and Liabilities
Share Capital 2 2 2 2
Total Reserves 12.01 12.56 13.84 16.76
Borrowings 3.49 3.91 3.15 2.1
Other N/C liabilities 0.22 0.09 0.17 0.22
Current liabilities 9.51 11.4 12.77 12.09
Total Liabilities 27.23 29.96 31.92 33.17
Assets
Net Block 6.24 5.05 6.63 7.27
Capital WIP 0 0 0 0.93
Intangible WIP 0 0 0 0
Investments 1.37 5.35 2.63 2.28
Loans & Advances 0.09 0.13 0.17 0.23
Other N/C Assets 0 0 0 0
Current Assets 19.53 19.43 22.48 22.47
Total Assets 27.23 29.96 31.92 33.17
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017
Profit from operations 2.1 4.49
Adjustment 1.94 1.91
Changes in Assets & Liabilities 0.08 -1.56
Tax Paid -0.25 -0.62
Operating Cash Flow 3.87 4.22
Investing Cash Flow 0.21 -2.37
Financing Cash Flow -0.11 -5.72
Net Cash Flow 3.97 -3.87

Corporate Actions

Company News

 No Latest News available for this company.
Report us
Last Updated on:
Brief about MDC Pharmaceuticals
X